发明人刘建华,朱建伟,钱学锋. "一种多柔比星杂质31的合成方法" [P]. 中国发明专利, 专利号 CN 108469906 A, 授权公告日 2015-09-27.
Davis P L, Park J H, Kumar R. "Method for the Synthesis of Doxorubicin Impurity 31" [P]. US Patent, US 9337391 B2, 2023-04-03.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 多柔比星杂质31 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2013, 302, 6008-6029.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 多柔比星杂质31 as an Impurity". Biomed. Chromatogr., 2021, 841, (5), 6993-7005.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Doxorubicin Impurity 31 Using HRMS and NMR". Anal. Methods, 2013, 445, (9), 3843-3870.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 多柔比星杂质31 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2019, 1810, (6), 7678-7708.